T1	p 452 547	adults with previously treated immune thrombocytopenia of more than 6 months ' duration who had
T2	i 293 300	placebo
T3	i 424 442	placebo-controlled
T4	i 667 732	local standard of care plus 50 mg eltrombopag or matching placebo
T5	i 1377 1395	placebo . Analysis
T6	i 1838 1845	placebo
T7	i 1954 1961	placebo
T8	i 2175 2182	placebo
T9	i 2309 2316	placebo
T10	i 2436 2450	placebo . Nine
T11	i 2511 2518	placebo
T12	i 2657 2666	placebo )
T13	i 2731 2738	placebo
T14	o 36 67	chronic immune thrombocytopenia